(Alliance News) - AorTech International PLC on Wednesday said it will be granted a patent in the US, and said it eyes animal testing of its ElastEon polymers "in the coming weeks".
The patent will be issued on June 9, AorTech said, and it relates to usage of biostable polyurethane or polyurea in medical devices and polymetric heart valves.
Chair Bill Brown said: "We are delighted that at the same time as major steps are being made in the development of our ElastEon enabled medical devices, our intellectual property portfolio relating to the ElastEon family of world class biostable polymers has been expanded further by the grant of this latest US patent.
"We currently anticipate reaching the significant milestone of commencing animal testing on the ElastEon sealed graft in the coming weeks."
Shares in the company were 6.4% higher at 111.75 pence each in London on Wednesday afternoon.
By Eric Cunha; ericcunha@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
